The Parathyroid is a Target Organ for FGF23 in Rats

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2007 Nov 10

PMID 17992255

Citations 387

Authors

Iddo Z Ben-Dov

Hillel Galitzer

Vardit Lavi-Moshayoff

Regina Goetz

Makoto Kuro-O

Moosa Mohammadi

Roy Sirkis

Tally Naveh-Many

Justin Silver

Affiliations

Soon will be listed here.

Abstract

Phosphate homeostasis is maintained by a counterbalance between efflux from the kidney and influx from intestine and bone. FGF23 is a bone-derived phosphaturic hormone that acts on the kidney to increase phosphate excretion and suppress biosynthesis of vitamin D. FGF23 signals with highest efficacy through several FGF receptors (FGFRs) bound by the transmembrane protein Klotho as a coreceptor. Since most tissues express FGFR, expression of Klotho determines FGF23 target organs. Here we identify the parathyroid as a target organ for FGF23 in rats. We show that the parathyroid gland expressed Klotho and 2 FGFRs. The administration of recombinant FGF23 led to an increase in parathyroid Klotho levels. In addition, FGF23 activated the MAPK pathway in the parathyroid through ERK1/2 phosphorylation and increased early growth response 1 mRNA levels. Using both rats and in vitro rat parathyroid cultures, we show that FGF23 suppressed both parathyroid hormone (PTH) secretion and PTH gene expression. The FGF23-induced decrease in PTH secretion was prevented by a MAPK inhibitor. These data indicate that FGF23 acts directly on the parathyroid through the MAPK pathway to decrease serum PTH. This bone-parathyroid endocrine axis adds a new dimension to the understanding of mineral homeostasis.

Citing Articles

Influence of Klotho Protein Levels in Obesity and Sarcopenia: A Systematic Review.

Ariadel-Cobo D, Estebanez B, Gonzalez-Arnaiz E, Garcia-Perez M, Rivera-Viloria M, Pintor de la Maza B Int J Mol Sci. 2025; 26(5).

PMID: 40076542 PMC: 11900336. DOI: 10.3390/ijms26051915.

Aging: A struggle for beneficial to overcome negative factors made by muscle and bone.

Welc S, Brotto M, White K, Bonewald L Mech Ageing Dev. 2025; 224:112039.

PMID: 39952614 PMC: 11893237. DOI: 10.1016/j.mad.2025.112039.

Unlocking the mysteries of n-oxPTH: implications for CKD patients.

Zhang L, Cao H Front Endocrinol (Lausanne). 2025; 15():1455783.

PMID: 39829956 PMC: 11738944. DOI: 10.3389/fendo.2024.1455783.

The transcription factor BBX regulates phosphate homeostasis through the modulation of FGF23.

Lee S, Kim J, Ihn H, Choi J, Kwon T, Shin H Exp Mol Med. 2024; 56(11):2436-2448.

PMID: 39482539 PMC: 11612488. DOI: 10.1038/s12276-024-01341-9.

Influence of N- and/or P-restriction on bone metabolism in young goats.

Zillinger L, Liesegang A, Hustedt K, Schnepel N, Sauerwein H, Schmicke M Br J Nutr. 2024; 132(7):874-886.

PMID: 39402760 PMC: 11576093. DOI: 10.1017/S0007114524002150.

References

Kolek O, Hines E, Jones M, LeSueur L, Lipko M, Kiela P . 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol. 2005; 289(6):G1036-42. DOI: 10.1152/ajpgi.00243.2005. View

Silver J, Naveh-Many T, Mayer H, Schmelzer H, Popovtzer M . Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986; 78(5):1296-301. PMC: 423816. DOI: 10.1172/JCI112714. View

Naveh-Many T, Silver J . Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest. 1990; 86(4):1313-9. PMC: 296864. DOI: 10.1172/JCI114840. View

Liu S, Zhou J, Tang W, Jiang X, Rowe D, Quarles L . Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006; 291(1):E38-49. DOI: 10.1152/ajpendo.00008.2006. View

Stubbs J, Liu S, Tang W, Zhou J, Wang Y, Yao X . Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol. 2007; 18(7):2116-24. DOI: 10.1681/ASN.2006121385. View

Rodriguez M, Almaden Y, Canadillas S, Canalejo A, Siendones E, Lopez I . The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands. Am J Physiol Renal Physiol. 2007; 292(5):F1390-5. DOI: 10.1152/ajprenal.00262.2006. View

. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000; 26(3):345-8. DOI: 10.1038/81664. View

Carling T, Rastad J, Szabo E, Westin G, Akerstrom G . Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab. 2000; 85(5):2000-3. DOI: 10.1210/jcem.85.5.6607. View

Hofer A, Brown E . Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol. 2003; 4(7):530-8. DOI: 10.1038/nrm1154. View

10.

Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt K . Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281(10):6120-3. PMC: 2637204. DOI: 10.1074/jbc.C500457200. View

11.

Kato Y, Arakawa E, Kinoshita S, Shirai A, Furuya A, Yamano K . Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem Biophys Res Commun. 2000; 267(2):597-602. DOI: 10.1006/bbrc.1999.2009. View

12.

Li S, Watanabe M, Yamada H, Nagai A, Kinuta M, Takei K . Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct. 2005; 29(4):91-9. DOI: 10.1247/csf.29.91. View

13.

White K, Jonsson K, Carn G, Hampson G, Spector T, Mannstadt M . The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab. 2001; 86(2):497-500. DOI: 10.1210/jcem.86.2.7408. View

14.

Bai X, Miao D, Goltzman D, Karaplis A . The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem. 2003; 278(11):9843-9. DOI: 10.1074/jbc.M210490200. View

15.

Naveh-Many T, Rahamimov R, Livni N, Silver J . Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest. 1995; 96(4):1786-93. PMC: 185815. DOI: 10.1172/JCI118224. View

16.

Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A . alpha-Klotho as a regulator of calcium homeostasis. Science. 2007; 316(5831):1615-8. DOI: 10.1126/science.1135901. View

17.

Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, Hashimoto N . Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 2004; 565(1-3):143-7. DOI: 10.1016/j.febslet.2004.03.090. View

18.

Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse H . Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology. 2004; 145(7):3087-94. DOI: 10.1210/en.2003-1768. View

19.

Yamashita T, Konishi M, Miyake A, Inui K, Itoh N . Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem. 2002; 277(31):28265-70. DOI: 10.1074/jbc.M202527200. View

20.

Levi R, Ben-Dov I, Lavi-Moshayoff V, Dinur M, Martin D, Naveh-Many T . Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol. 2005; 17(1):107-12. DOI: 10.1681/ASN.2005070679. View